Tonix Pharmaceuticals Holding Corp (TNXP)

CapEx to Revenue

4.33%

Quarterly · Period ending:

TNXP logo

TNXP CapEx to Revenue

Latest reported4.33%
TNXP Quarterly CapEx/Revenue (0.00% → 4.33%)
High-resolution chart · PNG

TNXP capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tonix Pharmaceuticals Holding Corp CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.334%
24.6002%
34.7681%
30.8651%
127.0771%
0.247%
0.1162%
0.3189%
0.0798%
4.3513%
11.5904%
45.45%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-1,000%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.